buthionine sulfoximine

DRUG3 trials

Sponsors

New Approaches to Neuroblastoma Therapy Consortium, Duke University

Conditions

Melanoma (Skin)Neuroblastoma

Phase 1

N99-02: Melphalan and Buthionine Sulfoximine

CompletedNCT00005835

New Approaches to Neuroblastoma Therapy ConsortiumNeuroblastoma

Start: 2001-08-31End: 2016-04-30Updated: 2023-04-10

Chemotherapy in Treating Children With Neuroblastoma

CompletedNCT00002730

New Approaches to Neuroblastoma Therapy ConsortiumNeuroblastoma

Start: 1996-06-30Updated: 2024-11-20

A Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant Melanoma

WithdrawnNCT00661336

Duke UniversityMelanoma (Skin)

Start: 2008-04-30Updated: 2015-03-13